Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
This is a study to evaluate the immunogenicity and safety of GlaxoSmithKline (GSK) Biologicals combined measles-mumps-rubella varicella candidate vaccine given to healthy children in their second year of life.
Epistemonikos ID: ec3431a2b2b98bee24d853bd693b04c40ac86e51
First added on: May 04, 2024